Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

GnRH Analogues in Clinical Practice

Pharmacological Applications

  • The American College of Physicians recommends GnRH agonists for the treatment of central precocious puberty, as they work by desensitizing gonadotrophs through continuous stimulation, reducing LH release and halting ovarian stimulation 1
  • The American Society of Clinical Oncology recommends GnRH agonists for ovarian suppression in premenopausal women with hormone receptor-positive breast cancer, as they reduce the risk of recurrence 2

Controversial Applications

  • The American Society of Clinical Oncology and the European Society for Medical Oncology state that GnRH analogues are not an effective method for fertility preservation during chemotherapy, and established methods like embryo or egg cryopreservation should be preferred 3, 4

Side Effects and Considerations

  • The American College of Obstetricians and Gynecologists notes that common side effects of GnRH agonists include menopausal symptoms and accelerated bone loss with prolonged use, highlighting the need for careful patient selection and monitoring 2
  • Complete ovarian suppression with GnRH analogues is not achieved for several weeks after administration, emphasizing the importance of timely initiation of treatment 4

REFERENCES

1

Management of Precocious Puberty in Girls [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Role of GnRH Agonists and Antagonists in Breast Cancer Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Fertility Preservation with GnRH Analogues during Chemotherapy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025